IP Library Granted Patent US 12,403,299
Granted Patent B2
US 12,403,299 · App. 17/741,717 · Granted Sep 2, 2025

Apparatuses, systems, and methods for the treatment of damaged tissue

Inventors: Daryl Lawson (Kalamazoo, MI); Christopher Brian Arena (Blacksburg, VA); Tim A. Fischell (Kalamazoo, MI)
Assignee: Adlore, Inc.
A61N1/0484A61N1/0468A61N1/28A61N1/37282
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,403,299
App. No.
17/741,717
Granted
Sep 2, 2025
Kind
B2
Abstract

A therapeutic apparatus for treating damaged tissue on a limb or body of a subject includes a wearable adapted to cover and be secured to the limb or body of a subject over damaged tissue. The wearable being configured to reduce pressure on the damaged tissue and adapted to deliver one or more treatments selected from the group consisting of heat, oxygen, electrical current, and light to the damaged tissue.

Claims (29)

1. A therapeutic apparatus for treating damaged tissue on a limb or body portion of a subject, said therapeutic apparatus comprising:

a wearable adapted to cover and be secured to the limb or body portion of a subject over damaged tissue, said wearable configured to contact the limb or body portion around the damaged tissue but being configured to off-load pressure from the damaged tissue but in the presence of atmospheric pressure; and

said wearable adapted to apply electrical current to induce electrical stimulation and to globally warm the limb or body portion at the same time as applying the electrical current to raise the temperature of the limb or body portion and not just provide local warming of the damaged tissue wherein at least 40% of the limb or body portion is warmed.

2. The therapeutic apparatus according to claim 1 , wherein said wearable includes a recessed region that extends over the damaged tissue and makes no contact with the damage tissue to thereby off-load pressure from the damage tissue.

3. The therapeutic apparatus according to claim 1 , wherein said wearable includes at least two electrodes that are located so that they contact the skin of the patient around or adjacent the damage tissue when the patient is wearing the apparatus, and wherein said at least two electrodes are configured to apply said electrical current and induce said electrical stimulation to the skin of the patient surrounding or adjacent the damaged tissue.

4. The therapeutic apparatus according to claim 2 , further comprising an electrical pulse generator in electrical communication with an electrical supply and electrically coupled with said electrodes, said electrical pulse generator being configured to generate electrical pulse stimulation with said at least two of said electrodes and configured to apply the electrical pulse stimulation with a biphasic wave form in a range of 1 mA to 50 mA with a pulse width in a range of 50 to 500 microseconds.

5. The therapeutic apparatus according to claim 1 , wherein said wearable covers an extent of a limb and further includes an insulation layer to distribute heat over the extent of the limb.

6. The therapeutic apparatus according to claim 5 , wherein the insulation layer comprises a foil.

7. The therapeutic apparatus according to claim 6 , wherein said foil forms a passive warming system to warm the limb.

8. The therapeutic apparatus according to claim 2 , wherein said apparatus is adapted to supply oxygen to the damaged tissue in the recessed region.

9. The therapeutic apparatus according to claim 8 , wherein said wearable includes a conduit adapted to couple to an oxygen source surfaced mounted or integrated into the wearable to supply oxygen to the damaged tissue.

10. The therapeutic apparatus according to claim 9 , wherein said recess forms a chamber over the damaged tissue when the therapeutic apparatus is applied the patient over the damaged tissue.

11. The therapeutic apparatus according to claim 6 , in combination with a separate device for supplying oxygen to the damaged tissue, and said wearable being configured to extend over the separate device and to be secured to the subject over the separate device.

12. The therapeutic apparatus according to claim 1 , further comprising a UV lamp to directly or indirectly apply UV light to the damaged tissue.

13. The therapeutic apparatus according to claim 1 , further comprising one or more sensors, at least one sensor being configured to (1) measure at least one indicator of wound healing, (2) track of the use of the device and/or (3) track the condition of the subject.

14. The therapeutic apparatus according to claim 13 , further comprising a transmitter for sending information, about or relative to the apparatus or the patient to a remote computer, a handheld device, a nurse call station, and/or a server.

15. The therapeutic apparatus according to claim 1 , wherein said wearable is configured to cover at least the foot of the subject, said wearable being configured to conform to the patient's foot and including a recess in the region of the damaged tissue to off-load pressure on the damaged tissue.

16. A therapeutic apparatus for treating damaged tissue on a limb or body portion of a subject, said therapeutic apparatus comprising:

a wearable to cover and be secured to the limb or body portion of the subject over damaged tissue, and said wearable being configured to off-load pressure from the damaged tissue;

a pair of electrodes to apply electrical stimulation to the damaged tissue; and

said wearable being adapted to apply one or more treatments selected from the group consisting of (1) heat wherein the heat applies global warming to the limb or body portion of the subject, (2) oxygen wherein the oxygen is directed to the damaged tissue, and (2) light wherein the light is directed to the damaged tissue.

17. The therapeutic apparatus according to claim 16 , wherein when said wearable has a recess in the region of the damaged tissue to off-load pressure and thereby reduce pressure on the damaged tissue, and further comprising a UV lamp to directly or indirectly apply UV light to the damaged tissue.

18. The therapeutic apparatus according to claim 17 , further comprising one or more sensors, at least one sensor being configured to measure at least one indicator of wound healing.

19. The therapeutic apparatus according to claim 17 , further comprising one or more sensors, at least one sensor being configured to track of the use of the device and/or condition of the subject.

20. The therapeutic apparatus according to claim 19 , further comprising a transmitter for sending information about or relative to the apparatus or the subject to a remote computer, a handheld device, a nurse call station, and/or a server.

21. The therapeutic apparatus according to claim 20 , wherein said wearable is adapted to supply oxygen to the damaged tissue.

22. The therapeutic apparatus according to claim 16 , wherein said wearable is configured to cover at least the foot of the subject, said wearable being configured to conform to the subject's foot and including a recess in the region of the damaged tissue to off-load pressure and thereby reduce pressure on the damaged tissue.

23. The therapeutic apparatus according to claim 13 , wherein at least one sensor is configured to (1) track of the use of the device and/or (2) track the condition of the subject.

24. The therapeutic apparatus according to claim 16 , wherein said wearable is adapted to apply globally warming to the limb or body portion and not just provide local warming of the damaged tissue wherein at least 40% of the limb or body portion is warmed.

Continuity (6)
Continuation In Part 17324705 · May 19, 2021
Continuation In Part 17004243 · Aug 27, 2020
Continuation 16267635 · Feb 5, 2019
Provisional Application 62893025 · Aug 28, 2019
Provisional Application 62627028 · Feb 6, 2018
Related Publication 20220265996A1 · Aug 25, 2022
References Cited (72)
US 5974342A · Petrofsky · 1999 [cited by applicant]
US 6094599A · Bingham et al. · 2000 [cited by applicant]
US 7144390B1 · Hannigan et al. · 2006 [cited by applicant]
US 7483738B2 · Tamarkin et al. · 2009 [cited by applicant]
US 7540848B2 · Hannigan et al. · 2009 [cited by applicant]
US 7689285B2 · Garabet · 2010 [cited by applicant]
US 8372022B2 · Hannigan et al. · 2013 [cited by applicant]
US 8388562B2 · Baker et al. · 2013 [cited by applicant]
US 8827941B2 · Davis et al. · 2014 [cited by applicant]
US 8840573B2 · Neustaedter et al. · 2014 [cited by applicant]
US 8882687B2 · Hannigan et al. · 2014 [cited by applicant]
US 9333282B2 · Van der Hulst · 2016 [cited by applicant]
US 9526816B2 · Toth · 2016 [cited by applicant]
US D787077S · Lindsay · 2017 [cited by applicant]
US 9642414B2 · Lindsay et al. · 2017 [cited by applicant]
US 9724243B2 · Hannigan et al. · 2017 [cited by applicant]
US 10058478B2 · Schnetz et al. · 2018 [cited by applicant]
US 10130805B2 · Schonenberger et al. · 2018 [cited by applicant]
US 10166387B2 · Bergelin et al. · 2019 [cited by applicant]
US 10206604B2 · Bergelin et al. · 2019 [cited by applicant]
US 10207031B2 · Toth · 2019 [cited by applicant]
US 11338128B2 · Lawson · 2022 [cited by examiner]
US 20020026226A1 · Ein · 2002 [cited by applicant]
US 20040173220A1 · Harry · 2004 [cited by examiner]
US 20040254624A1 · Johnson · 2004 [cited by applicant]
US 20050015124A1 · Irwin · 2005 [cited by applicant]
US 20070016271A1 · Hammond · 2007 [cited by applicant]
US 20070179585A1 · Chandler · 2007 [cited by examiner]
US 20070264354A1 · Herman · 2007 [cited by applicant]
US 20070282400A1 · Gorham · 2007 [cited by applicant]
US 20080027509A1 · Andino et al. · 2008 [cited by applicant]
US 20090240216A1 · Hannigan et al. · 2009 [cited by applicant]
US 20100210983A1 · Baker et al. · 2010 [cited by applicant]
US 20100234837A1 · Alfano · 2010 [cited by applicant]
US 20100268300A1 · Ramos Leal et al. · 2010 [cited by applicant]
US 20100292746A1 · Gorham · 2010 [cited by applicant]
US 20100318018A1 · Schonenberger et al. · 2010 [cited by applicant]
US 20110125204A1 · Louise · 2011 [cited by applicant]
US 20110213319A1 · Blott et al. · 2011 [cited by applicant]
US 20110214315A1 · Mayer et al. · 2011 [cited by applicant]
US 20120259266A1 · Quisenberry · 2012 [cited by examiner]
US 20120316480A1 · Nolan et al. · 2012 [cited by applicant]
US 20130158634A1 · Ron Edoute et al. · 2013 [cited by applicant]
US 20130274629A1 · Duesterhoft et al. · 2013 [cited by applicant]
US 20130304007A1 · Toth · 2013 [cited by applicant]
US 20130326912A1 · Lindsay et al. · 2013 [cited by applicant]
US 20140052054A1 · Qunsenberry · 2014 [cited by applicant]
US 20140206947A1 · Isserow et al. · 2014 [cited by applicant]
US 20150075030A1 · Walborn et al. · 2015 [cited by applicant]
US 20160015962A1 · Shokoueinejad Maragheh et al. · 2016 [cited by applicant]
US 20160045735A1 · Chang et al. · 2016 [cited by applicant]
US 20160058999A1 · Skiba · 2016 [cited by applicant]
US 20160081580A1 · Bergelin et al. · 2016 [cited by applicant]
US 20160143555A1 · Decre et al. · 2016 [cited by applicant]
US 20160184575A1 · Schonenberger et al. · 2016 [cited by applicant]
US 20160213521A1 · Bacon et al. · 2016 [cited by applicant]
US 20160213552A1 · Lindsay · 2016 [cited by applicant]
US 20170056233A1 · Kelly · 2017 [cited by applicant]
US 20170128117A1 · Myers et al. · 2017 [cited by applicant]
US 20170296805A1 · Mower · 2017 [cited by applicant]
US 20180008000A1 · Chanda et al. · 2018 [cited by applicant]
US 20190134396A1 · Toth · 2019 [cited by examiner]
US 20190240475A1 · Lawson et al. · 2019 [cited by applicant]
US 20190297992A1 · Raza et al. · 2019 [cited by applicant]
US 20190388667A1 · Xu · 2019 [cited by applicant]
WO 2007088348A2 · 2007 [cited by applicant]
WO WO2017190049A1 · 2017 [cited by examiner]
International Search Report for PCT/US2019/16596 dated Apr. 30, 2019; 2 pages. [cited by applicant]
Written Opinion of the International Searching Authority for PCT/US2019/16596 dated Apr. 30, 2019; 5 pages. [cited by applicant]
International Search Report for PCT/US2020/48087 dated Nov. 20, 2020; 2 pages. [cited by applicant]
Written Opinion of the International Searching Authority for PCT/US2020/48087 dated Nov. 20, 2020; 20 pages. [cited by applicant]
Supplemental European Search Report from corresponding European Application No. 20857765.0, completed Aug. 8, 2023. [cited by applicant]